Cargando…
A roadmap for translational cancer glycoimmunology at single cell resolution
Cancer cells can evade immune responses by exploiting inhibitory immune checkpoints. Immune checkpoint inhibitor (ICI) therapies based on anti-CTLA-4 and anti-PD-1/PD-L1 antibodies have been extensively explored over the recent years to unleash otherwise compromised anti-cancer immune responses. How...
Autores principales: | Peixoto, Andreia, Miranda, Andreia, Santos, Lúcio Lara, Ferreira, José Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013178/ https://www.ncbi.nlm.nih.gov/pubmed/35428302 http://dx.doi.org/10.1186/s13046-022-02335-z |
Ejemplares similares
-
Core fucosylation and its roles in gastrointestinal glycoimmunology
por: Zhang, Nian-Zhu, et al.
Publicado: (2023) -
Glycoproteogenomics: Setting the Course for Next-generation Cancer Neoantigen Discovery for Cancer Vaccines
por: Ferreira, José Alexandre, et al.
Publicado: (2021) -
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
por: Peixoto, Andreia, et al.
Publicado: (2019) -
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
por: Azevedo, Rita, et al.
Publicado: (2017) -
Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies
por: Lima, Luís, et al.
Publicado: (2016)